Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:668 (18 March), doi:10.1136/bmj.332.7542.668-a
EDITORMurray highlights the recent advances in diagnosis and management of multiple sclerosis.1 This is particularly important in managing a clinically isolated episode of optic neuritis. Current UK ophthalmological management of a unilateral episode of typical optic neuritis is generally not to investigate or to treat.2 However, with the development of the McDonald criteria for diagnosing multiple sclerosis and advances in magnetic resonance imaging of lesions,3 4 there is potential for early diagnosis of multiple sclerosis.
This is important as new treatments such as recombinant interferon beta-1a may reduce the development of clinically definite multiple sclerosis.5 Future best clinical practice in the management of acute optic neuritis may therefore be to investigate all patients to identify those with multiple sclerosis who would benefit from early treatment.
|
Peter D Cackett, ophthalmology specialist registrar
pete{at}pdcackett.demon.co.uk Princess Alexandra Eye Pavilion, Edinburgh EH3 9HA
James Cameron, ophthalmology senior house officer, Harry Bennett, ophthalmology consultant
Princess Alexandra Eye Pavilion, Edinburgh EH3 9HA